Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program.
Saved in:
| Title: | Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program. |
|---|---|
| Authors: | Venner E; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA. venner@bcm.edu., Muzny D; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Smith JD; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Walker K; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Neben CL; Color Health, Burlingame, CA, USA., Lockwood CM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA., Empey PE; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA., Metcalf GA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Kachulis C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mian S; NIH All of Us Research Program, National Institutes of Health Office of the Director, Bethesda, MD, USA., Musick A; NIH All of Us Research Program, National Institutes of Health Office of the Director, Bethesda, MD, USA., Rehm HL; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA., Harrison S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gabriel S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Nickerson D; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Zhou AY; Color Health, Burlingame, CA, USA., Doheny K; Center for Inherited Disease Research, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ozenberger B; NIH All of Us Research Program, National Institutes of Health Office of the Director, Bethesda, MD, USA., Topper SE; Color Health, Burlingame, CA, USA., Lennon NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA. |
| Corporate Authors: | All of Us Research Program Regulatory Working Group |
| Source: | Genome medicine [Genome Med] 2022 Mar 28; Vol. 14 (1), pp. 34. Date of Electronic Publication: 2022 Mar 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-994X |
|---|---|
| DOI: | 10.1186/s13073-022-01031-z |
